NCT07727551

Brief Summary

Knee osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage wear, leading to pain, stiffness, and joint swelling. It is highly prevalent in aging populations and is strongly associated with obesity and previous joint injury. OA affects millions of individuals worldwide, with incidence and prevalence increasing markedly with age and resulting in significant functional disability The primary therapeutic goals in the management of knee osteoarthritis are pain reduction and improvement of joint mobility. Total knee arthroplasty is considered one of the most effective surgical interventions for relieving pain and restoring function in patients with severe knee osteoarthritis. Nevertheless, residual pain and limited functional improvement remain the most frequent causes of patient dissatisfaction following TKA Genicular nerve radiofrequency ablation (GNRFA) has emerged as an innovative treatment option for symptomatic knee osteoarthritis. This technique has been shown to reduce pain and improve function, with clinical benefits often observed as early as one week after treatment. GNRFA consistently provides short-term pain relief (3 to 6 months) and, in some cases, longer-lasting benefits. The hypothesis tested in this study is whether GNRFA performed at least two weeks preoperatively can reduce postoperative pain and improve postoperative function.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Jun 2026Jun 2027

Study Start

First participant enrolled

June 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 4, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 27, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

July 27, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 4, 2026

Last Update Submit

July 22, 2026

Conditions

Keywords

Radiofrequency ablationGenicular nerve

Outcome Measures

Primary Outcomes (2)

  • Postoperative Oxford Knee Score

    A difference of 5 points in Oxford Knee Score between groups will be considered significant. Range: 0 to 48, higher is better

    Three months post-operative

  • Western Ontario and McMaster Universities Osteoarthritis Index postoperative

    A 12 point difference will be considered significant Range: 0 to 96, higher is better

    3 months postoperatively

Secondary Outcomes (4)

  • Numerical rating scale pain postoperative

    Three months post-operatively

  • Chronic regional pain syndrome post-operatively

    3 months post-operatively

  • Morphine consumption

    Three months post-operatively

  • Patient satisfaction

    Three months postoperatively

Study Arms (2)

Radiofrequency

EXPERIMENTAL

Patients in this arm will receive genicular nerve radiofrequency ablation between 2 to 6 weeks before undergoing elective total knee replacement

Procedure: Radiofrequency ablation of the genicular nerve, 42 degrees Celsius for 120 seconds

Control

NO INTERVENTION

Patients in this group will not receive any intervention before undergoing elective total knee replacement

Interventions

Radiofrequency ablation of the genicular nerves (upper medial, upper lateral and lower medial nerves), at 42 C for 120 seconds each, after injection of 5ml lidocaine 2% for each nerve.

Radiofrequency

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18 and 60
  • Elective total knee arthroplasty
  • to 6 weeks before the procedure
  • AND either of:
  • BMI \> 35
  • Diabetes under insulin
  • Anxiety disorder
  • Treated depressive disorder
  • Widespread pain disorder or central sensitisation disorder
  • Chronic pain at a different site
  • Catastrophising
  • Sleep disorder
  • preoperative EVA 7 or more
  • OKS 25 or less
  • WOMAC 50 or more
  • +2 more criteria

You may not qualify if:

  • Previous prosthetic surgery on the same knee (i.e. redo surgery, open reduction internal fixation, knee hemiarthroplasty)
  • Major psychiatric disorder (i.e. major depression, schizophrenia)
  • Patient refusal
  • Inability to communicate with the patient and obtain informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iris South Hospitals

Brussels, 1050, Belgium

RECRUITING

Related Publications (22)

  • Murray DW, Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr AJ, Dawson J. The use of the Oxford hip and knee scores. J Bone Joint Surg Br. 2007 Aug;89(8):1010-4. doi: 10.1302/0301-620X.89B8.19424.

    PMID: 17785736BACKGROUND
  • Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005 Jan;64(1):29-33. doi: 10.1136/ard.2004.022905. Epub 2004 Jun 18.

    PMID: 15208174BACKGROUND
  • Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001 Aug;45(4):384-91. doi: 10.1002/1529-0131(200108)45:43.0.CO;2-0.

    PMID: 11501727BACKGROUND
  • Clement ND, Afzal I, Demetriou C, Deehan DJ, Field RE, Kader D. There is no clinically important difference in the Oxford knee scores between one and two years after total knee arthroplasty: The one-year score could be used as the benchmark timepoint to assess outcome. Knee. 2020 Aug;27(4):1212-1218. doi: 10.1016/j.knee.2020.05.015. Epub 2020 Jun 25.

    PMID: 32711884BACKGROUND
  • Jordan K, Dunn KM, Lewis M, Croft P. A minimal clinically important difference was derived for the Roland-Morris Disability Questionnaire for low back pain. J Clin Epidemiol. 2006 Jan;59(1):45-52. doi: 10.1016/j.jclinepi.2005.03.018. Epub 2005 Nov 4.

    PMID: 16360560BACKGROUND
  • Hasoon J, Orhurhu VJ, Yazdi C. Genicular Nerve Blocks for the Management of Chronic Knee Pain Related to Osteoarthritis - A Case Series. Orthop Rev (Pavia). 2024 Dec 3;16:126046. doi: 10.52965/001c.126046. eCollection 2024.

    PMID: 39640541BACKGROUND
  • Shanahan EM, Robinson L, Lyne S, Woodman R, Cai F, Dissanayake K, Paddick K, Cheung G, Voyvodic F. Genicular Nerve Block for Pain Management in Patients With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial. Arthritis Rheumatol. 2023 Feb;75(2):201-209. doi: 10.1002/art.42384. Epub 2022 Nov 11.

    PMID: 36369781BACKGROUND
  • GARDNER E. The innervation of the knee joint. Anat Rec. 1948 May;101(1):109-30. doi: 10.1002/ar.1091010111. No abstract available.

    PMID: 18915634BACKGROUND
  • Fari G, de Sire A, Fallea C, Albano M, Grossi G, Bettoni E, Di Paolo S, Agostini F, Bernetti A, Puntillo F, Mariconda C. Efficacy of Radiofrequency as Therapy and Diagnostic Support in the Management of Musculoskeletal Pain: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022 Feb 26;12(3):600. doi: 10.3390/diagnostics12030600.

    PMID: 35328153BACKGROUND
  • Kvarstein G, Mawe L, Indahl A, Hol PK, Tennoe B, Digernes R, Stubhaug A, Tonnessen TI, Beivik H. A randomized double-blind controlled trial of intra-annular radiofrequency thermal disc therapy--a 12-month follow-up. Pain. 2009 Oct;145(3):279-286. doi: 10.1016/j.pain.2009.05.001. Epub 2009 Aug 3.

    PMID: 19647940BACKGROUND
  • van Kleef M, Barendse GA, Kessels A, Voets HM, Weber WE, de Lange S. Randomized trial of radiofrequency lumbar facet denervation for chronic low back pain. Spine (Phila Pa 1976). 1999 Sep 15;24(18):1937-42. doi: 10.1097/00007632-199909150-00013.

    PMID: 10515020BACKGROUND
  • Koh W, Choi SS, Karm MH, Suh JH, Leem JG, Lee JD, Kim YK, Shin J. Treatment of chronic lumbosacral radicular pain using adjuvant pulsed radiofrequency: a randomized controlled study. Pain Med. 2015 Mar;16(3):432-41. doi: 10.1111/pme.12624. Epub 2014 Dec 19.

    PMID: 25530347BACKGROUND
  • Shanthanna H, Chan P, McChesney J, Thabane L, Paul J. Pulsed radiofrequency treatment of the lumbar dorsal root ganglion in patients with chronic lumbar radicular pain: a randomized, placebo-controlled pilot study. J Pain Res. 2014 Jan 10;7:47-55. doi: 10.2147/JPR.S55749. eCollection 2014 Jan 10.

    PMID: 24453500BACKGROUND
  • Li J, Guan T, Zhai Y, Zhang Y. Risk factors of chronic postoperative pain after total knee arthroplasty: a systematic review. J Orthop Surg Res. 2024 May 29;19(1):320. doi: 10.1186/s13018-024-04778-w.

    PMID: 38811979BACKGROUND
  • Wylde V, Blom AW. The failure of survivorship. J Bone Joint Surg Br. 2011 May;93(5):569-70. doi: 10.1302/0301-620X.93B5.26687. No abstract available.

    PMID: 21511918BACKGROUND
  • Choi YJ, Ra HJ. Patient Satisfaction after Total Knee Arthroplasty. Knee Surg Relat Res. 2016 Mar;28(1):1-15. doi: 10.5792/ksrr.2016.28.1.1. Epub 2016 Feb 29.

    PMID: 26955608BACKGROUND
  • Medical Advisory Secretariat. Total knee replacement: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(9):1-51. Epub 2005 Jun 1.

    PMID: 23074478BACKGROUND
  • Lenguerrand E, Wylde V, Gooberman-Hill R, Sayers A, Brunton L, Beswick AD, Dieppe P, Blom AW. Trajectories of Pain and Function after Primary Hip and Knee Arthroplasty: The ADAPT Cohort Study. PLoS One. 2016 Feb 12;11(2):e0149306. doi: 10.1371/journal.pone.0149306. eCollection 2016.

    PMID: 26871909BACKGROUND
  • Schug SA, Lavand'homme P, Barke A, Korwisi B, Rief W, Treede RD; IASP Taskforce for the Classification of Chronic Pain. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain. 2019 Jan;160(1):45-52. doi: 10.1097/j.pain.0000000000001413.

    PMID: 30586070BACKGROUND
  • Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. doi: 10.1016/S0140-6736(06)68700-X.

    PMID: 16698416BACKGROUND
  • Macrae WA. Chronic post-surgical pain: 10 years on. Br J Anaesth. 2008 Jul;101(1):77-86. doi: 10.1093/bja/aen099. Epub 2008 Apr 22.

    PMID: 18434337BACKGROUND
  • Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020 Sep 1;161(9):1976-1982. doi: 10.1097/j.pain.0000000000001939.

    PMID: 32694387BACKGROUND

Study Officials

  • Francesco Zuccarini, MD

    Iris South Hospitals

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefano Doria, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2026

First Posted

July 27, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

July 27, 2026

Record last verified: 2026-07

Locations